The first symposium organized by the EUROMAC consortium will gather stakeholders active in the field of muscle glycogenosis from across the globe. It will be held on  the 1st April 2016. 

This symposium aims to raise awareness around the world of McArdle disease and very rare muscle glycogenolitic disorders with exercise intolerance as major symptom  and to foster international collaborations involving researchers and clinicians. To do so we organized a masterclass to discuss from diagnosis, management, animals models and latest research in the field. 

Date: Friday 1st April 2016

Venue: National Hospital for Neurology and Neurosurgery

           33 Queen Square Lecture Theatre

           London, UK

Symposium fee – £30

Students and doctors in training – Free

euromacregistry.eu

Registration: 

 

FULL PROGRAMME

9:00-9:20 Registration and Coffee 

9:20-9:30 Welcome: Dr Ros Quinlivan on behalf of Euromac consortium 

9:30-10:00 What is Euromac?: Dr Ramon Marti (Barcelona, Spain) 

10:00-10:30 McArdle Disease: Dr Ros Quinlivan (London, UK) 

10:30-11:00 The life of a typical McArdle person: Mr Andrew Wakelin (Wales) 

11:00-11:15 COFFEE 

11:15-11:45 Functional outcome measures for McArdle disease and related disorders: Professor John Vissing (Copenhagen, Denmark) 

11:45-12:15 Exercise as therapy for muscle Glycogenoses: Professor Ron Haller (Dallas, USA) 

12:15-12:45 Strength training for McArdle disease: Professor Alejandro Lucia (Madrid, Spain) 

12:45-13:30 LUNCH 

13:30-14:00 Diagnosis and management of GSD 7: Professor Andrea Martinuzzi (Conegliano, Italy) 

14:00-14:30 An update on new developments in the management of Pompe disease: Antonio Toscano (Messino, Italy) 

14:30:15:00 Disorders of glycogen synthesis: Professor Anders Oldfors (Stockholm, Sweden) 

15:00-15:30 TEA 

15:30-1600 Diagnosis and management of GSD3: Dr Robin Lachmann (London, UK) 

16:00-16:30 Animal models for muscle glycogenosis: Dr Tomas Pinos (Barcelona, Spain) 

Meeting Close